BRAINSTORM CELL THERAPEUTICS INC. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $56.50 million as of 2014-06-30, per its 10-Q filed 2014-08-12.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2014-08-12
- 2014-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $56.50M.
- 2014-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $54.52M.
- 2013-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $52.41M.
- 2013-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $51.19M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2014-06-30 | $56.50M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $54.52M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $52.41M 10-Q · filed 2014-08-12 |
| 2013-09-30 | $51.19M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $50.11M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $48.59M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $47.51M 10-K · filed 2014-03-27 |
| 2012-09-30 | $46.93M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $45.78M 10-Q/A · filed 2012-08-29 |
| 2012-03-31 | $44.95M 10-Q · filed 2012-05-11 |
| 2011-12-31 | $44.08M 10-K · filed 2013-03-14 |
| 2011-09-30 | $42.66M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $41.96M 10-Q/A · filed 2011-09-07 |
| 2010-12-31 | $40.16M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |